Examination of the adverse event related to influenza virus vaccines in children with idiopathic nephrotic syndrome

Examination of the adverse event related to influenza virus vaccines in children with idiopathic nephrotic syndrome - Examination of the adverse event related to influenza virus vaccines in children with idiopathic nephrotic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028658

Enrollment

Registered

2017-08-14

Start date

2017-08-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic nephrotic syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children diagnosed as idiopathic nephrotic syndrome

Exclusion criteria

Exclusion criteria: Children diagnosed as any nephritis or secondary nephrotic syndrome, and experienced allergic reaction related influenza virus vaccine

Design outcomes

Primary

Measure	Time frame
Relapse rate of nephrotic syndrome within 1 month after influenza virus vaccines compared with those in 6 months before influenza virus vaccines	—

Countries

Japan

Contacts

Public ContactShingo Ishimori

Kakogawa central city hospital Department of pediatrics

shingo-i0324os@live.jp0794515500

Outcome results